Skip to main content

Table 8 Survival analysis of three treatments on five BIC subtypes

From: Subtype identification from heterogeneous TCGA datasets on a genomic scale by multi-view clustering with enhanced consensus

Treatment

All

Subtype 1

Subtype 2

Subtype 3

Subtype 4

Subtype 5

Cytoxan

3.29e-2

1.98e-5

4.94e-2

0.310

0.447

0.226

Adriamycin

1.32e-2

1.24e-3

0.646

0.892

0.095

0.760

Arimidex

0.19

0.654

0.607

1.82e-2

0.433

0.352

  1. The treatment could generate significantly improved treatment effects in the subtype of p-value in boldface